Reagent Kit for Simultaneous Detection of IgM and IgG Antibodies to SARS-CoV-2 Causing COVID-19

Reagent Kit for Simultaneous Detection of IgM and IgG Antibodies to SARS-CoV-2 Causing COVID-19

Method: Solid-phase Indirect Enzyme-Linked Immunosorbent Assay (ELISA)
Product Name: "SARS-CoV-2 IgM/IgG Screen"
Certification: TU 21.20.23-005-41390295-2020
Batch Numbers: No. 20061, No. 20062I

Kit Components:

• Immunosorbent plate, individually packaged with silica gel – 1 pc
• K(+) – Inactivated positive control sample – 1 vial (1 ml)
• K(-) – Inactivated negative control sample – 1 vial (2 ml)
• FSB-Tx26 – Concentrated washing buffer – 1 vial (30 ml)
• RPO – Sample diluent – 1 vial (12 ml)
• KG-1(x11) – Conjugate concentrate No.1 – 1 vial (1.3 ml)
• RRK – Conjugate dilution buffer – 1 vial (13 ml)
• TMB (x11) – TMB substrate concentrate – 1 vial (1.3 ml)
• RRT – TMB dilution buffer – 1 vial (13 ml)
• Stop reagent – 1 vial (7 ml)
• Plate sealing film – 3 pcs
• Instructions for use – 1 copy

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Simultaneous Detection of IgM and IgG Antibodies to SARS-CoV-2 Causing COVID-19, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.